{
    "2018-11-08": [
        [
            {
                "time": "2018-01-02",
                "original_text": "乐视网：贾跃亭持股再度减少，被司法处置用于偿债",
                "features": {
                    "keywords": [
                        "乐视网",
                        "贾跃亭",
                        "持股减少",
                        "司法处置",
                        "偿债"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "传媒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "药明康德：首次公开发行境外上市外资股获证监会批复",
                "features": {
                    "keywords": [
                        "药明康德",
                        "H股",
                        "证监会",
                        "批复"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "药明康德：发行H股获中国证监会核准",
                "features": {
                    "keywords": [
                        "药明康德",
                        "H股",
                        "证监会",
                        "核准"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "药明康德：首次公开发行H股获证监会批复，共发行不超过2.11亿股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "H股",
                        "证监会",
                        "批复",
                        "发行量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "药明康德：前三季净利润增长81% 买入评级",
                "features": {
                    "keywords": [
                        "药明康德",
                        "净利润",
                        "增长",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "医药生物行业专题报告:收入整体稳健,Q3扣非净利润增速放缓,内部分化持续",
                "features": {
                    "keywords": [
                        "医药生物",
                        "收入稳健",
                        "Q3",
                        "扣非净利润",
                        "增速放缓",
                        "内部分化"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}